Related Experiment Video
Updated: Aug 24, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
The Shp-1 and Shp-2, tyrosine phosphatases, are recruited on cell membrane in two distinct molecular complexes
Mariarosaria Incoronato1, Amelia D'Alessio, Simona Paladino
1Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli "Federico II", Via S. Pansini 5, 80131, Naples, Italy.
Abstract:
The Shp-2 and Shp-1 non-transmembrane tyrosine phosphatases display different and even opposing effects on downstream signaling events initiated by Ret activation. By using rat pheochromocytoma-derived PC12 cells, here we studied the interactions of Shp-2 and Shp-1 with two activated mutants of Ret receptor, Ret(C634Y) and Ret(M918T). Each of these mutated receptors causes inheritance of distinct cancer syndromes, multiple endocrine neoplasia (MEN) type 2A and type 2B, respectively. We show that: (i) both Shp-1 and Shp-2 are associated to a multiprotein complex that includes Ret mutants; (ii) the Shp-1-Ret complexes are distinct from Shp-2-Ret complexes, and these complexes are differently distributed inside and outside lipid rafts; (iii) constitutively activated Ret proteins neither directly bind to nor are substrates of these phosphatases. Our results well support the evidence that Ret complexes within and outside rafts mediate distinct biological functions, and indicate that the presence of either Shps participates to determine such functions.
Insights
Shp-1 and Shp-2 phosphatases interact differently with Ret receptor mutants, influencing cancer syndromes like MEN 2A and 2B. Their distinct complexes within and outside lipid rafts mediate varied biological functions.
Area of Science:
- Molecular Biology
- Cell Signaling
- Cancer Genetics
Background:
- The Ret receptor tyrosine kinase is crucial for development and implicated in cancers.
- Shp-1 and Shp-2 phosphatases modulate Ret signaling pathways.
- Mutations in Ret cause Multiple Endocrine Neoplasia (MEN) types 2A and 2B.
Purpose of the Study:
- To investigate the distinct interactions of Shp-1 and Shp-2 with activated Ret mutants.
- To determine how these interactions affect downstream signaling and cellular localization.
- To elucidate the role of phosphatases in Ret-mediated oncogenesis.
Main Methods:
- Utilized rat pheochromocytoma-derived PC12 cells.
- Studied interactions with Ret(C634Y) and Ret(M918T) mutants.
- Analyzed protein complex formation and localization within lipid rafts.
Main Results:
- Both Shp-1 and Shp-2 associate with Ret mutants in distinct multiprotein complexes.
- Shp-1-Ret and Shp-2-Ret complexes exhibit differential localization inside and outside lipid rafts.
- Activated Ret proteins do not directly bind to or act as substrates for Shp-1 or Shp-2.
Conclusions:
- Ret complexes within and outside lipid rafts mediate distinct biological functions.
- The presence and type of Shp phosphatases contribute to determining these functions.
- Understanding these interactions is key to deciphering Ret-driven cancer mechanisms.
Related Concept Videos
Receptor Tyrosine Kinases
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Amplifying Signals via Enzymatic Cascade
TGF - β Signaling Pathway

